GGTA1 KO Thymokidney
Phase 1/2Recruiting 0 watching 0 views this week💤 Quiet
38
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
ESRD (End-Stage Renal Disease)
Conditions
ESRD (End-Stage Renal Disease), Kidney Transplantation, Xenotransplantation
Trial Timeline
Mar 1, 2026 → Mar 1, 2076
NCT ID
NCT07224763About GGTA1 KO Thymokidney
GGTA1 KO Thymokidney is a phase 1/2 stage product being developed by United Therapeutics for ESRD (End-Stage Renal Disease). The current trial status is recruiting. This product is registered under clinical trial identifier NCT07224763. Target conditions include ESRD (End-Stage Renal Disease), Kidney Transplantation, Xenotransplantation.
Hype Score Breakdown
Clinical
13
Activity
8
Company
7
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07224763 | Phase 1/2 | Recruiting |
Competing Products
17 competing products in ESRD (End-Stage Renal Disease)
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Roxadustat | AstraZeneca | Phase 3 | 77 |
| Doravirine | Merck | Approved | 85 |
| MK-2060 + Placebo | Merck | Phase 1 | 33 |
| Induction therapy + Corticosteroids + EVR+rCNI + MPA+sCNI | Novartis | Approved | 85 |
| Mycophenolic Acid (Myfortic) | Novartis | Approved | 85 |
| Avacopan | Amgen | Phase 1 | 32 |
| [¹⁴C]Etelcalcetide | Amgen | Phase 1 | 32 |
| apixaban | Bristol Myers Squibb | Phase 2 | 51 |
| ISIS 416858 + Placebo | Bayer | Phase 2 | 49 |
| ISIS 416858 + Placebo | Bayer | Phase 2 | 49 |
| 10 GE Xenokidney | United Therapeutics | Phase 1/2 | 38 |
| Dianeal + Physioneal + Extraneal + Nutrineal | Baxter | Phase 3 | 74 |
| Physioneal + Dianeal + Extraneal + Nutrineal | Baxter | Approved | 82 |
| Dianeal + Dianeal, Extraneal, Nutrineal | Baxter | Phase 3 | 74 |
| Acellular Tissue Engineered Vessel (ATEV) | Humacyte | Phase 3 | 69 |
| Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate | Rockwell Medical | Phase 2 | 44 |
| soluble ferric pyrophosphate (SFP) | Rockwell Medical | Pre-clinical | 15 |